| Teresa C Tobey, CRNA | |
|
222 Medical Cir, Morehead, KY 40351-1179 | |
| (606) 783-6500 | |
| (606) 783-6904 |
| Full Name | Teresa C Tobey |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 222 Medical Cir, Morehead, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578779666 | NPI | - | NPPES |
| 7100027970 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 076806 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergenchealth Pllc | 1355606641 | 585 |
News Archive
Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases that are common among the elderly and that can progress to acute leukemia. The findings could lead to targeted therapies against MDS and prevent MDS-related cancers. The study is published today in the online edition of the journal Blood.
› Verified 2 days ago
| Entity Name | Purple Martin Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902234057 PECOS PAC ID: 4486882834 Enrollment ID: O20140111000001 |
News Archive
Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases that are common among the elderly and that can progress to acute leukemia. The findings could lead to targeted therapies against MDS and prevent MDS-related cancers. The study is published today in the online edition of the journal Blood.
› Verified 2 days ago
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20190618003098 |
News Archive
Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases that are common among the elderly and that can progress to acute leukemia. The findings could lead to targeted therapies against MDS and prevent MDS-related cancers. The study is published today in the online edition of the journal Blood.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teresa C Tobey, CRNA 222 Medical Cir, Morehead, KY 40351-1179 Ph: (606) 783-6500 | Teresa C Tobey, CRNA 222 Medical Cir, Morehead, KY 40351-1179 Ph: (606) 783-6500 |
News Archive
Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.
Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.
A discovery by scientists at Dana-Farber Cancer Institute and University of Texas Southwestern Medical Center presents drug developers with an entirely new tack in targeting one of the most-wanted molecular culprits in cancer.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases that are common among the elderly and that can progress to acute leukemia. The findings could lead to targeted therapies against MDS and prevent MDS-related cancers. The study is published today in the online edition of the journal Blood.
› Verified 2 days ago
Lauren Harwood, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6513 Fax: 606-783-6489 | |
Denita Joy Ray, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 Fax: 606-783-6904 | |
Emily Sue Mason, NP-C Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6521 Fax: 606-783-6904 | |
Cynthia Jo Blankenship, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6504 | |
Cindy D Hanner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 | |
Philip W Vankersen, MD Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 Fax: 606-783-6904 | |
Kristie Lynn Mullins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Circle, Morehead, KY 40351 Phone: 606-783-6500 Fax: 606-783-6570 |